Clinical trial
The Effect of Sublingual Nitroglycerin on Absolute Coronary Blood Flow: A Randomised, Placebo-controlled, Mechanistic Trial
NCT06823843 is registered in ClinicalTrials.gov with VZW Cardiovascular Research Center Aalst as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Sublingual Nitroglycerin on Absolute Coronary Blood Flow: A Randomised, Placebo-controlled, Mechanistic Trial
- Lead sponsor
- VZW Cardiovascular Research Center Aalst
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 1, 2024
- Completion date
- September 30, 2024
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
angina (stable), coronary arterial disease (cad)